Machine Learning

Confluent Cloud for Government has achieved FedRAMP Moderate authorization, enabling federal agencies to adopt real-time data streaming to modernize services.

Newtek Bank launches a seven-day business loan up to $350k, using AI to offer a 10-year term that directly challenges high-cost, short-term financing.

New analysis of Phase 1 data for NKGen Biotech’s troculeucel suggests cognitive benefits, offering a potential new weapon against neuroinflammation.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

With its new Disaggregated Spine architecture and ultra-efficient switches, Nexthop AI aims to slash costs and power use for hyperscalers and NeoClouds.

In the quest to drug the 'undruggable,' Erasca consolidates worldwide control of its promising pan-RAS inhibitor, setting the stage for a global showdown.

A new AI biomarker analyzes blood vessels in CT scans, offering earlier, more accurate predictions of which patients will benefit from immunotherapy.

With a new Wabash partnership, SpecSync aims to slash complex equipment quote times from weeks to minutes, signaling a major shift for industrial sales.

A new campaign by Palvella Therapeutics and key partners aims to educate and empower patients with a rare disease, a strategic move ahead of a potential new drug.

Kiddie Academy's "STEM Adventures" offers free, hands-on science events nationwide, blending community outreach with a strategy to lead in early education.

National Vision's annual scholarship rewards optometry students exploring AI and telemedicine, revealing a strategic investment in the future of eye care.

Sabre appoints Niklas Andréen as CCO to accelerate airline adoption of its new AI-native tech, signaling a strategic pivot from development to execution.

In a strategic move to fortify national security, X-Bow is acquiring Evolution Space, boosting US rocket motor production and hypersonic capabilities.

Embodied AI firm XGSynBot unveils its Z1 wheeled robot, designed for factory floors, not labs, aiming to solve manufacturing's 'automation paradox'.

A new cybersecurity firm backed by industry veterans has raised $125M to unleash autonomous AI agents that reason and act at machine speed.

Quantum firm Zapata adds industry veterans to its board, signaling a strategic shift in the quantum race from hardware supremacy to software application.

Agenus activates a key manufacturing pact with Zydus, scaling production for its promising BOT+BAL cancer therapy ahead of regulatory filings and market launch.

A new drug targeting the root cause of deadly device infections enters a pivotal trial, offering hope to millions and challenging a $20 billion problem.

Extreme Connect 2026 showcases an AI-first strategy to challenge industry giants, promising a new era of automated, intelligent enterprise networks.

As Zepp Health unveils its 2025 performance, all eyes are on its fight for profitability and market share against giants like Garmin and Apple.